In one of the latest studies, researchers from Iran analyzed the impact of a proprietary formula containing plant-based CBD and THC in a 10:1 ratio, which was created by Yas Daru, a pharmaceutical firm in Tehran. It was given to 50 diabetic patients diagnosed with type 2 diabetes sublingually to help keep glucose as well as cholesterol levels in check. The study participants administered the sublingual spray twice a day for 8 weeks.
New Jersey’s THC beverage market is heading into the most consequential stretch of its short…
Mormon Wives star Mikayla Matthews says medical cannabis was “literally life-changing” for her nerve pain…
Chains reorder every two weeks and earn twice the discounts. Independents stock the same breadth…
We head to Canna Country Farms in Humboldt for Legendary Strains to discover the Ocimene…
Cannabis advocates should take the lesson here too. The industry doesn't need to inflate its…
Twenty patient associations from across northeastern Brazil are meeting in Fortaleza this month, inside a…